The new law modernizes access by enabling online sales of PSE-containing medicines and removing outdated barriers to purchase, while continuing to rely on Tennessee’s real-time electronic tracking system to prevent misuse.
“OTC medicines are a cornerstone of self-care, enabling millions of Americans to safely and effectively manage common conditions without a prescription,” said CHPA's David Spangler.
The awards spotlight strategic innovation and execution across key categories, including digital marketing, multicultural and inclusive campaigns, shopper marketing, and product launches.
“CHPA is privileged to be guided by outstanding industry leaders who volunteer their time and expertise to serve on our board of directors,” said CHPA President and CEO Scott Melville.
Sawaya has been deeply involved with CHPA for more than two decades, serving as a trusted advisor to member companies and contributing to broader industry dialogue around consumer healthcare.
National survey of 21,000 sdults captures seven-day snapshot of medication use; OTC and prescription medicines used in tandem to address distinct health needs.
Legislation reaffirms the FDA is the sole authority to regulate dietary supplements, reinforcing a single, national standard for ingredient safety and oversight.
By Scott Melville, president and CEO of the Consumer Healthcare Products Association
CHPA appreciates the ongoing recognition that dietary supplements support individuals in meeting nutrient needs when diet alone falls short.
CHPA said the bill would boost OTC market innovation by clarifying and standardizing the review process for new and updated self-care products.
Over 350 industry leaders from 100 companies gathered at The Bellevue Hotel for this milestone event and a major fundraiser for the Foundation’s consumer education initiatives.
Discouraging acetaminophen use when taken as directed by a health professional could push pregnant patients toward NSAIDs or no treatment, both of which can adversely affect pregnancy outcomes.
Decades of use, FDA safety reviews, and leading medical groups confirm the safety of acetaminophen when used as directed.
“Current research has not established a causal link between acetaminophen use and adverse neurodevelopmental outcomes.”
This year’s competition had the highest participation rate since its inception in 2019, with a 32% increase in submissions over 2024.
Backed by CHPA member companies Kenvue and Colgate-Palmolive, and developed in collaboration with The Skin Cancer Foundation and the American Dental Association (ADA), the programs will reach more than 1.2 million students nationwide during the back-to-school season.
